BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Stroumpoulis KI, Pantazopoulos IN, Xanthos TT. Hypertrophic cardiomyopathy and sudden cardiac death. World J Cardiol 2010; 2(9): 289-298 [PMID: 21160605 DOI: 10.4330/wjc.v2.i9.289]
URL: https://www.wjgnet.com/1949-8462/full/v2/i9/289.htm
Number Citing Articles
1
Kelly C. Lear. Encyclopedia of Forensic and Legal Medicine. 2025;  doi: 10.1016/B978-0-443-21441-7.00041-8
2
Antony Macido. A native review of hypertrophic cardiomyopathy. Emergency and Critical Care Medicine 2026;  doi: 10.1097/EC9.0000000000000192
3
Juan A. Vílchez, Diana Hernández-Romero, Francisco Ruiz-Espejo, Antonio Garcia-Honrubia, Mariano Valdés, Pedro Martínez-Hernández, Francisco Marín. Collagen peptides, interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy. Clinical Chemistry and Laboratory Medicine 2011; 49(9) doi: 10.1515/CCLM.2011.642
4
Riya Bhasin, Yazan AlJamal, Hiroto Kitahara, John Blair, Husam H. Balkhy. Robotic unroofing of myocardial bridge of the left anterior descending coronary artery in a patient with hypertrophic obstructive cardiomyopathy and previous septal myectomy. Journal of Cardiology Cases 2024; 29(5) doi: 10.1016/j.jccase.2024.01.001
5
Kelly C. Lear-Kaul. Investigation of Sudden Death in Athletes: The Fittest Bodies in the Morgue. Academic Forensic Pathology 2014; 4(3) doi: 10.23907/2014.049
6
Chao-Yi Chen, Jyh-Gang Leu, Kuan-Yu Lin, Chin-Yu Shih, Yao-Jen Liang. Serotonin receptor subtype-2B signaling is associated with interleukin-18-induced cardiomyoblast hypertrophy in vitro. Asian Biomedicine 2022; 16(2) doi: 10.2478/abm-2022-0010
7
Mahdi Ahmed, Alaa Eldeeb, Maryam Saghir, Alyaa Ahmed Ibrahim, Mohammad Rayyan Faisal, Raveen Mujeeb, Bassam Hegazy, Mohamed Zabady, Amr Ibrahim, Karim Othman Abdelnaim, Walid Bechibchi, Humam Al-Machtomi, Ehsanullah Alokozay, Mohaimen Mohammed Al-Machtomi, Irfan Ullah, Mohamed Fawzi Hemida. Cardiac Arrest and Cardiomyopathy Related Mortality in the United States, 1999-2025: Trends and Disparities. ASIDE Cardiovascular 2026; 1(1) doi: 10.71079/ASIDE.CV.040326320
8
Meryl Musicante, Hannah H. Kim, Yuanjian Chen, Fang Liao, Syamal K. Bhattacharya, Lu Lu, Yao Sun. Regulation of endothelial nitric oxide synthase in cardiac remodeling. International Journal of Cardiology 2022; 364 doi: 10.1016/j.ijcard.2022.05.013
9
Suman Nag, Sampath K. Gollapudi, Carlos L. del Rio, James A. Spudich, Robert McDowell. Mavacamten, a precision medicine for hypertrophic cardiomyopathy: From a motor protein to patients. Science Advances 2023; 9(30) doi: 10.1126/sciadv.abo7622
10
Saikat Mitra, Kollengode Ramanathan, Graeme MacLaren. Post-operative management of hypertrophic obstructive cardiomyopathy. Asian Cardiovascular and Thoracic Annals 2022; 30(1) doi: 10.1177/02184923211069189
11
Pieter A. Vriesendorp, Arend F.L. Schinkel, Max Liebregts, Dominic A.M.J. Theuns, Johan van Cleemput, Folkert J. ten Cate, Rik Willems, Michelle Michels. Validation of the 2014 European Society of Cardiology Guidelines Risk Prediction Model for the Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. Circulation: Arrhythmia and Electrophysiology 2015; 8(4) doi: 10.1161/CIRCEP.114.002553
12
Wenqing Wang, Yue Jiang, Xuan Pan, Dong Chen, Hui Yang, Wang Pan, Mingjie Pan, Bin Wang. HDAC6 deficiency exacerbates atherosclerosis via STAT3-K685 acetylation-mediated CD36/SR-A upregulation in macrophages. Cell Death & Disease 2025; 17(1) doi: 10.1038/s41419-025-08344-y
13
U. Bartoszuk, B.W. Keene, M. Baron Toaldo, N. Pereira, N. Summerfield, J. Novo Matos, T.M. Glaus. Holter monitoring demonstrates that ventricular arrhythmias are common in cats with decompensated and compensated hypertrophic cardiomyopathy. The Veterinary Journal 2019; 243 doi: 10.1016/j.tvjl.2018.11.005
14
Alessandra Riccio, Ashley M. Shilling. Unique Medical Considerations for the Athlete Undergoing Anesthesia. Clinics in Sports Medicine 2022; 41(2) doi: 10.1016/j.csm.2021.11.009
15
Ana Perez-Asensio, Helena Llamas-Gomez, Ana Lara-Palomo, Alberto Villar-Ruiz, Cesar Jimenez-Mendez, Julian Palomino-Doza. A New Era in the Management of Hypertrophic Cardiomyopathy. Reviews in Cardiovascular Medicine 2025; 26(10) doi: 10.31083/RCM44503
16
Michael Ayers, Christopher M. Kramer. Cardiovascular Magnetic Resonance. 2027;  doi: 10.1016/B978-0-443-12497-6.00025-7
17
Yueqin Cai, Jue Tu, Shuizhen Pan, Jianping Jiang, Qiyang Shou, Yun Ling, Yunxiang Chen, Dejun Wang, Weiji Yang, Letian Shan, Minli Chen. Medicinal effect and its JP2/RyR2-based mechanism of Smilax glabra flavonoids on angiotensin II-induced hypertrophy model of cardiomyocytes. Journal of Ethnopharmacology 2015; 169 doi: 10.1016/j.jep.2015.04.026
18
Dena Mohamed Naguib Abdel Moawed, Hanan Hosny Hassan, Elham E. Megahed, Budoor Mohammed Almusaifer, Dalia Samy Sabet, Amany Shabaiek, Sally Saied Kamel, Ghadeer M. M. Abdelaal. Sudden cardiac death associated with non-atherosclerotic cardiac conditions: a case series. Egyptian Journal of Forensic Sciences 2026; 16(1) doi: 10.1186/s41935-026-00538-5
19
Yu Li, Zhen Chen, Bingxin Cheng, Jinlei Li, Fen Ai. A bibliometric and visual analysis of implantable cardioverter defibrillator use in hypertrophic cardiomyopathy: 2000–2025. Journal of Cardiothoracic Surgery 2026; 21(1) doi: 10.1186/s13019-026-04231-5
20
Dolina Gencheva, Petya Angelova, Kameliya Genova, Slavena Atemin, Mila Sleptsova, Tihomir Todorov, Fedya Nikolov, Donka Ruseva, Vanyo Mitev, Albena Todorova. A Cautionary Tale of Hypertrophic Cardiomyopathy—From “Benign” Left Ventricular Hypertrophy to Stroke, Atrial Fibrillation, and Molecular Genetic Diagnostics: A Case Report and Review of Literature. International Journal of Molecular Sciences 2024; 25(17) doi: 10.3390/ijms25179385
21
Nicholas Sheffle, Tracey Bowden. Pre-participation screening for hypertrophic cardiomyopathy in young athletes. British Journal of Cardiac Nursing 2014; 9(11) doi: 10.12968/bjca.2014.9.11.551
22
Brian Cowie. The Preoperative Patient With a Systolic Murmur. Anesthesiology and Pain Medicine 2015; 5(6) doi: 10.5812/aapm.32105
23
Mohd Batchi, Hashaam Ghafoor, Anwar Ul Huda, Ali O. Mohamed Bel Khair, Osman Ahmed, Ekambaram Karunakaran, Siddalingappa Suresh Orekondi, Shameen Salavudheen, Mohamed Sheriff Poolakundan, Jagadish Adiga, Tafazzul Husain, Aisha Abdalraheem Hamad Elawad, Ahmed Hussein Mohamed Almaqadma. Anesthetic Considerations in Athletes: A Review. Cureus 2025;  doi: 10.7759/cureus.81040
24
Eugene S. Yim, Edward F. Gillis, Krystin Ojala, James MacDonald, Frederick C. Basilico, Gianmichael D. Corrado. Focused Transthoracic Echocardiography by Sports Medicine Physicians. Journal of Ultrasound in Medicine 2013; 32(2) doi: 10.7863/jum.2013.32.2.333
25
Amogh Verma, Ayush Anand, Vaishnavi Akshay Patel, Ajeet Singh, Areeba Ahsan, Sai Gautham Kanagala, Hritvik Jain, Rohit Chandra Dey, Mahalaqua Nazli Khatib, Quazi Syed Zahiruddin, Abhay M Gaidhane, Divya Sharma, Sarvesh Rustagi, Prakasini Satapathy. Redefining Management in Hypertrophic Cardiomyopathy: The Role and Challenges of Exercise Rehabilitation. Cardiology in Review 2024;  doi: 10.1097/CRD.0000000000000766
26
Alessandra Riccio, Ashley M. Shilling. Unique Medical Considerations for the Athlete Undergoing Anesthesia. Anesthesiology Clinics 2024; 42(2) doi: 10.1016/j.anclin.2023.11.005
27
Celeste M Murtha, John R Dobson, Anthony B Olinger. A Cadaveric Evaluation of Hypertrophic Obstructive Cardiomyopathy. Cureus 2023;  doi: 10.7759/cureus.40870
28
Dareuosh Shackebaei, Farid Feizollahi, Mahvash Hesari, Gholamreza Bahrami. The Effect of Diazepam on the Function of Hypertrophied Rats’ Hearts in Ischemia-Reperfusion Conditions. International Cardivascular Research Journal 2016; 10(2) doi: 10.17795/icrj-10(2)89
29
Hussein H. Khachfe, Hamza A. Salhab, Mohamad Y. Fares, Hassan M. Khachfe. Current State of Hypertrophic Cardiomyopathy Clinical Trials. Global Heart 2019; 14(3) doi: 10.1016/j.gheart.2019.07.005
30
K. Savostyanov, A. Pushkov, I. Zhanin, N. Mazanova, S. Trufanov, A. Pakhomov, A. Alexeeva, D. Sladkov, A. Asanov, A. Fisenko. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology. Orphanet Journal of Rare Diseases 2022; 17(1) doi: 10.1186/s13023-022-02319-4
31
Andro Tawfik, Sara Amer, Patrick Wu, Su‐Boon Yong, Chin‐Yuan Yii. Cytomegalovirus seropositivity and its correlation with all‐cause mortality among US adults. Journal of Medical Virology 2024; 96(8) doi: 10.1002/jmv.29872
32
S. Marrakchi, I. Kammoun, E. Bennour, L. Laroussi, S. Kachboura. Risk stratification in hypertrophic cardiomyopathy. Herz 2020; 45(1) doi: 10.1007/s00059-018-4700-8
33
Priyanshi Gangwal, Siva Sai Kumar Pulagura, Vikas Meshram, Rohit Singh Jaggi, Sudeep Khera. Hypertrophic obstructive cardiomyopathy with associated pulmonary arteriopathy: A histopathologic perspective from sudden cardiac death. Journal of Forensic and Legal Medicine 2026; 123 doi: 10.1016/j.jflm.2026.103266
34
Arianne Clare Agdamag, Anders Westanmo, Amy Gravely, Natthapon Angsubhakorn, Lin Yee Chen, Selcuk Adabag. Mortality associated with antiarrhythmic medication for atrial fibrillation among patients with left ventricular hypertrophy. Pacing and Clinical Electrophysiology 2023; 46(7) doi: 10.1111/pace.14711
35
Debasish Das, Debasis Acharya, Tutan Das, Subhas Pramanik. Mega Coronary Arteries with Obstructive Coronary Artery Disease in Hypertrophic Obstructive Cardiomyopathy. Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging 2022; 6(1) doi: 10.4103/jiae.jiae_44_21
36
Grigorios Giamouzis, Apostolos Dimos, Andrew Xanthopoulos, John Skoularigis, Filippos Triposkiadis. Left ventricular hypertrophy and sudden cardiac death. Heart Failure Reviews 2022; 27(2) doi: 10.1007/s10741-021-10134-5
37
Dawn OʼReilly, Laura Beth Enos, Laura Hedlund, Kaylene Hood, Anna Kate Pruett, Daryl Rosenbaum, Reamer L. Bushardt. CME Prescreening of adolescent athletes: How much evaluation is enough?. Journal of the American Academy of Physician Assistants 2012; 25(11) doi: 10.1097/01720610-201211000-00010